Inhaled nebulized nitrite is a hypoxia-sensitive NO-dependent selective pulmonary vasodilator
The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
Abstract
The blood anion nitrite contributes to hypoxic vasodilation through a heme-based, nitric oxide (NO)-generating reaction with deoxyhemoglobin and potentially other heme proteins. We hypothesized that this biochemical reaction could be harnessed for the treatment of neonatal pulmonary hypertension, an NO-deficient state characterized by pulmonary vasoconstriction, right-to-left shunt pathophysiology and systemic hypoxemia. To test this, we delivered inhaled sodium nitrite by aerosol to newborn lambs with hypoxic and normoxic pulmonary hypertension. Inhaled nitrite elicited a rapid and sustained reduction ( approximately 65%) in hypoxia-induced pulmonary hypertension, with a magnitude approaching that of the effects of 20 p.p.m. NO gas inhalation. This reduction was associated with the immediate appearance of NO in expiratory gas. Pulmonary vasodilation elicited by aerosolized nitrite was deoxyhemoglobin- and pH-dependent and was associated with increased blood levels of iron-nitrosyl-hemoglobin. Notably, from a therapeutic standpoint, short-term delivery of nitrite dissolved in saline through nebulization produced selective, sustained pulmonary vasodilation with no clinically significant increase in blood methemoglobin levels. These data support the concept that nitrite is a vasodilator acting through conversion to NO, a process coupled to hemoglobin deoxygenation and protonation, and evince a new, simple and inexpensive potential therapy for neonatal pulmonary hypertension.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, recent studies have shown that much lower doses, nearphysiologic concentrations of circulating nitrite, also have vasodilatory effects in several species, 68,[107][108][109] including humans.110 -113”
From Nitrate-Nitrite-Nitric Oxide Pathway: Implications for Anesthesiology and Intensive Care (2010) · cites this paper as [112]
In the citing paper
“However, the vasodilatory potency of nitrite increases during hypoxia and acidosis probably because of enhanced reduction to bioactive nitric oxide.111,112,114”
From Nitrate-Nitrite-Nitric Oxide Pathway: Implications for Anesthesiology and Intensive Care (2010) · cites this paper as [112]
In the citing paper
“Similarly, nitrite administered via inhalation or infusion is a selective pulmonary vasodilator with increased activity in hypoxia[142–144]”
From Enterosalivary nitrate metabolism and the microbiome: Intersection of microbial metabolism, nitric oxide and diet in cardiac and pulmonary vascular health (2017) · cites this paper as [143]
In the citing paper
“Delivered via intravenous, inhaled, or oral routes, nitrite reduces pulmonary and right heart pressures and prevents or reverses characteristic vascular remodeling and right ventricular hypertrophy (RVH) in several animal models of PAH[15,117,143,146–149].”
From Enterosalivary nitrate metabolism and the microbiome: Intersection of microbial metabolism, nitric oxide and diet in cardiac and pulmonary vascular health (2017) · cites this paper as [143]
In the citing paper
“Heme dependent nitrite reduction to NO can be accomplished through different globin proteins including deoxyhemoglobin, deoxymyoglobin, neuroglobin, and cytoglobin [19, 87].”
From Inorganic nitrite therapy: historical perspective and future directions (2011) · cites this paper as [87]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation
Cosby, K., Partovi, K. S., Crawford, J. H., Patel, R. P., Reiter, C. D., Martyr, S., Yang, B. K., Waclawiw, M. A., Zalos, G., Xu, X., et al. (2003) · Nature Medicine · doi:10.1038/nm954 · Cited by 1,807
Self-citationIgnarro, L. J., Lippton, H., Edwards, J. C., Baricos, W. H., Hyman, A. L., Kadowitz, P. J., & Gruetter, C. A. (1981) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32738-2 · Cited by 1,633
Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction
Frostell, C., Fratacci, M. D., Wain, J. C., Jones, R., & Zapol, W. M. (1991) · Circulation · doi:10.1161/01.cir.83.6.2038 · Cited by 1,128
Inhaled Nitric Oxide in Full-Term and Nearly Full-Term Infants with Hypoxic Respiratory Failure
(1997) · New England Journal of Medicine · doi:10.1056/nejm199702273360901 · Cited by 865
Inhaled Nitric Oxide and Persistent Pulmonary Hypertension of the Newborn
Roberts, J. D., Fineman, J. R., Morin, F. C., Shaul, P. W., Rimar, S., Schreiber, M. D., Polin, R. A., Zwass, M. S., Zayek, M. M., Gross, I., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199702273360902 · Cited by 804
Enzyme-independent formation of nitric oxide in biological tissues
Zweier, J. L., Wang, P., Samouilov, A., & Kuppusamy, P. (1995) · Nature Medicine · doi:10.1038/nm0895-804 · Cited by 788
Low-Dose Nitric Oxide Therapy for Persistent Pulmonary Hypertension of the Newborn
Clark, R. H., Kueser, T. J., Walker, M. W., Southgate, W. M., Huckaby, J. L., Perez, J. A., Roy, B. J., Keszler, M., & Kinsella, J. P. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002173420704 · Cited by 731
Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn
KINSELLA, J. (1992) · The Lancet · doi:10.1016/0140-6736(92)92687-b · Cited by 730
Furchgott, R. F., & Bhadrakom, S. (1953) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)05163-8 · Cited by 655
Lauer, T., Preik, M., Rassaf, T., Strauer, B. E., Deussen, A., Feelisch, M., & Kelm, M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.221381098 · Cited by 585
Cited by
Items 101–200 of 279
Dietary nitrate supplementation in cardiovascular health: an ergogenic aid or exercise therapeutic?
Woessner, M. N., McIlvenna, L. C., Ortiz de Zevallos, J., Neil, C. J., & Allen, J. D. (2018) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00414.2017 · Cited by 50
“platelet aggregation(184, 233), and attenuation of pulmonary hypertension(96).”
BackgroundRenal carbonic anhydrases are involved in the reabsorption of endogenous nitrite
Chobanyan-Jürgens, K., Schwarz, A., Böhmer, A., Beckmann, B., Gutzki, F., Michaelsen, J. T., Stichtenoth, D. O., & Tsikas, D. (2012) · Nitric Oxide · doi:10.1016/j.niox.2012.01.005 · Cited by 54
“, nutrition, drugs) attracted considerable attention as potential pools and transporters of NO bioactivity in the body [3–8].”
BackgroundGrubina, R., Basu, S., Tiso, M., Kim-Shapiro, D. B., & Gladwin, M. T. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m705222200 · Cited by 50
Self-citationNitrate–Nitrite–Nitric Oxide Pathway in Pulmonary Arterial Hypertension Therapeutics
Sparacino-Watkins, C. E., Lai, Y.-C., & Gladwin, M. T. (2012) · Circulation · doi:10.1161/circulationaha.112.107821 · Cited by 49
Self-citationRosa, M. C. D., Alinovi, C. C., Galtieri, A., Scatena, R., & Giardina, B. (2007) · Gene · doi:10.1016/j.gene.2007.02.048 · Cited by 53
Erythrocyte nitric oxide transport reduced by a submembrane cytoskeletal barrier
Han, T. H., & Liao, J. C. (2005) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2005.01.013 · Cited by 47
“Recent studies have identified deoxyHb as a mediator in the formation of NO bioactivity [23, 37 ,38].”
BackgroundAugmentation of nitrite therapy in cerebral ischemia by NMDA receptor inhibition
Jung, K., Chu, K., Lee, S., Park, H.-K., Kim, J.-H., Kang, K., Kim, M., Lee, S. K., & Roh, J. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.11.081 · Cited by 50
Rix, P. J., Vick, A., Attkins, N. J., Barker, G. E., Bott, A. W., Alcorn, H., Gladwin, M. T., Shiva, S., Bradley, S., Hussaini, A., et al. (2015) · Clinical Pharmacokinetics · doi:10.1007/s40262-014-0201-y · Cited by 48
“In an ovine model of pulmonary hypertension induced by hypoxia, pulmonary artery pressure (PAP) was significantly reduced by inhalation of both NO gas and nebulized sodium nitrite, but the effects of NO gas disappeared immediately after cessation of exposure, while decreases in PAP following inhalation of nitrite were…”
BackgroundInfluentialSelf-citationHansen, T., Galougahi, K. K., Celermajer, D. S., Rasko, N. B., Tang, O., Bubb, K. J., & Figtree, G. A. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.05.005 · Cited by 50
Zahran, Z. N., Chooback, L., Copeland, D. M., West, A. H., & Richter-Addo, G. B. (2007) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2007.08.002 · Cited by 56
Red blood cells in the metabolism of nitric oxide‐derived peroxynitrite
Romero, N., Denicola, A., & Radí, R. (2006) · IUBMB Life · doi:10.1080/15216540600936549 · Cited by 77
Shiva, S., Rassaf, T., Patel, R. P., & Gladwin, M. T. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvq327 · Cited by 46
Self-citationHirsch, R. E., Sibmooh, N., Fucharoen, S., & Friedman, J. M. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6806 · Cited by 53
“Inhaled nebulized nitrite causes a sustained reduction in pulmonary arterial pressure in hypoxia-induced pulmonary hypertension in lambs (84) and hypoxia- or monocrotaline-induced pulmonary hypertension in mice and rats (215).”
BackgroundAnalysis of Nitric Oxide (NO) in Cerebral Vasospasm After Aneursymal Bleeding
Pluta, R. M., & Oldfield, E. H. (2007) · Reviews on Recent Clinical Trials · doi:10.2174/157488707779318062 · Cited by 50
Nitric oxide pathology and therapeutics in sickle cell disease
Kim‐Shapiro, D. B., & Gladwin, M. T. (2018) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-189009 · Cited by 55
Self-citationYang, S. C., Wo, Y., & Meyerhoff, M. E. (2014) · Analytica Chimica Acta · doi:10.1016/j.aca.2014.06.041 · Cited by 46
Pattillo, C. B., Bir, S., Rajaram, V., & Kevil, C. G. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvq297 · Cited by 43
Hemoglobin as a Nitrite Reductase Regulating Red Cell–Dependent Hypoxic Vasodilation
Gladwin, M. T. (2005) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.f294 · Cited by 42
Self-citationA “green” diet-based approach to cardiovascular health? Is inorganic nitrate the answer?
Rathod, K. S., Velmurugan, S., & Ahluwalia, A. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500313 · Cited by 42
Nitric oxide signalling and neuronal nitric oxide synthase in the heart under stress
Zhang, Y. H. (2017) · F1000Research · doi:10.12688/f1000research.10128.1 · Cited by 45
“For example, inhaled NO is registered to be applied to newborn babies with persistent pulmonary artery hypertension 106,107 to support ven-tilation-perfusion match and to prevent systemic ischaemia.”
BackgroundBuffering airway acid decreases exhaled nitric oxide in asthma
Gaston, B. M., Kelly, R., Urban, P., Liu, L., Henderson, E. M., Doctor, A., Teague, W. G., Fitzpatrick, A. M., ERZURUM, S. C., & Hunt, J. F. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.06.040 · Cited by 44
“Indeed, data suggesting that inhaled NO2 2 is converted to NO in vivo might reflect simple NO2 2 protonation in acidic parts of the airway.(29) However, airway pH mapping studies will be required to confirm this hypothesis.”
BackgroundGolwala, N. H., Hodenette, C., Murthy, S. N., Nossaman, B. D., & Kadowitz, P. J. (2009) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y09-101 · Cited by 41
“Nitrite can be reduced to NO by enzymatic mechanisms and by nonenzymatic disproportionation under severe conditions (Cosby et al. 2003; Hunter et al. 2004; Huang et al. 2005; Lundberg and Weitzberg 2005; Dalsgaard et al. 2007; Dejam et al. 2007; Casey et al. 2009).”
BackgroundSingh, M., Arya, A., Kumar, R., Bhargava, K., & Sethy, N. K. (2012) · Nitric Oxide · doi:10.1016/j.niox.2011.12.002 · Cited by 38
The role of inorganic nitrate and nitrite in CVD
Jackson, J. K., Patterson, A. J., MacDonald‐Wicks, L. K., & McEvoy, M. (2017) · Nutrition Research Reviews · doi:10.1017/s0954422417000105 · Cited by 40
“Sodium nitrite interventions in lamb and mouse models have shown reductions in pulmonary hypertension specifically during hypoxic conditions((164,165)).”
Iron(III)−Nitro Porphyrins: Theoretical Exploration of a Unique Class of Reactive Molecules
Conradie, J., & Ghosh, A. (2006) · Inorganic Chemistry · doi:10.1021/ic060362t · Cited by 37
Blood, A. B., Schroeder, H. J., Terry, M. H., Merrill-Henry, J., Bragg, S. L., Vrancken, K., Liu, T., Herring, J. L., Sowers, L. C., Wilson, S. M., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.001073 · Cited by 36
Self-citationPower, G. G., Bragg, S. L., Oshiro, B. T., Dejam, A., Hunter, C. J., & Blood, A. B. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00443.2007 · Cited by 41
“Animal studies of NO production from the reaction of nitrite with deoxyhemoglobin have demonstrated therapeutic potential for infused nitrite in models of myocardial infarction (11), intracerebral hemorrhage (33), and pulmonary hypertension (19).”
BackgroundSelf-citationRosa, M. C. D., Alinovi, C. C., Galtieri, A., Russo, A., & Giardina, B. (2008) · IUBMB Life · doi:10.1002/iub.15 · Cited by 44
Chapter 7 Effects of Nitric Oxide on Red Blood Cell Development and Phenotype
Čokić, V. P., & Schechter, A. N. (2008) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(07)00007-5 · Cited by 38
Self-citationEffect of chronic sodium nitrite therapy on monocrotaline-induced pulmonary hypertension
Pankey, E. A., Badejo, A. M., Casey, D. B., Lasker, G. F., Riehl, R. A., Murthy, S. N., Nossaman, B. D., & Kadowitz, P. J. (2012) · Nitric Oxide · doi:10.1016/j.niox.2012.02.004 · Cited by 35
“Nitrite therapy has been shown to have a beneficial effect in a wide variety of cardiovascular disorders in experimental animals [32,55,56,64].”
Endogenous Hemoprotein-Dependent Signaling Pathways of Nitric Oxide and Nitrite
Dent, M. R., DeMartino, A. W., Tejero, J., & Gladwin, M. T. (2021) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.1c01048 · Cited by 36
Self-citationBlood, A. B., & Power, G. G. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01259.2006 · Cited by 35
Self-citationIncreased nitrite reductase activity of fetal versus adult ovine hemoglobin
Blood, A. B., Tiso, M., Verma, S. T., Lo, J., Joshi, M. S., Azarov, I., Longo, L. D., Gladwin, M. T., Kim‐Shapiro, D. B., & Power, G. G. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00601.2008 · Cited by 35
“The physiological relevance of these reactions is supported by studies demonstrating the hypoxia-sensitive vasodilatory effects of nitrite in the rat aorta (12, 31), human forearm (12, 13, 39), primate (46), rat brain (49), and sheep lung (30).”
BackgroundSelf-citationCardioprotective actions of nitrite therapy and dietary considerations
Bryan, N. (2009) · Frontiers in Bioscience · doi:10.2741/3568 · Cited by 34
“Gladwin and colleagues proposed that nitrite transported in red cells are reduced to NO during hypoxia and therefore could account for the phenomenon of hypoxic vasodilatation and bring blood flow in line with tissue oxygen demand (67, 108).”
BackgroundExtending the translational potential of targeting NO/ cGMP ‐regulated pathways in the CVS
Papapetropoulos, A., Hobbs, A. J., & Topouzis, S. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12980 · Cited by 37
“…‘nitrate-nitrite-NO’ pathway lowers systemic blood pressure, protects against ischaemia–reperfusion (I/R) injury and ameliorates pulmonary hypertension (Hunter et al., 2004; Webb et al., 2004; 2008b; Hendgen-Cotta et al., 2008; Casey et al., 2009; Zuckerbraun et al., 2010; Baliga et al., 2012).”
BackgroundBlood, A. B., Terry, M. H., Merritt, T. A., Papamatheakis, D. G., Blood, Q., Ross, J. M., Power, G. G., Longo, L. D., & Wilson, S. M. (2012) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00126.2012 · Cited by 33
“The biphasic HPV response, if present in newborn lambs, is not detectable in vivo by measurement of pulmonary artery pressures (20).”
BackgroundSelf-citationImmuno-spin trapping of hemoglobin and myoglobin radicals derived from nitrite-mediated oxidation
Keszler, Á., Mason, R. P., & Hogg, N. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.09.005 · Cited by 32
Inhaled therapy for the management of perioperative pulmonary hypertension
Ramakrishna, H., Thunberg, C., & Morozowich, S. T. (2015) · Annals of Cardiac Anaesthesia · doi:10.4103/0971-9784.159811 · Cited by 35
“Although inhaled nitrite anion for the management of PH in humans has not yet been reported, studies involving induced PH in animal models suggest that inhaled nitrite anion is a selective pulmonary vasodilator.[46]”
BackgroundNitrosative stress in an animal model of necrotizing enterocolitis
Zamora, R., Bryan, N. S., Boyle, P., Wong, C., Milsom, A. B., Jaffe, R., Feelisch, M., & Ford, H. R. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.07.004 · Cited by 34
Liu, T., Schroeder, H. J., Power, G. G., & Blood, A. B. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102327 · Cited by 31
Self-citationPulmonary hypertension, nitric oxide and nitric oxide-releasing compounds
Hagan, G., & Pepke‐Żaba, J. (2011) · Expert Review of Respiratory Medicine · doi:10.1586/ers.11.5 · Cited by 30
Emerging therapeutics in pulmonary hypertension
Hensley, M. K., Levine, A. R., Gladwin, M. T., & Lai, Y. (2018) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00259.2017 · Cited by 34
“Inhaled and orally administered nitrite has been shown to reduce pulmonary pressures in sheep, mouse, and rat models of PH (20, 62, 75, 141) and has now advanced through phase 1 safety studies to phase 2A proof-of-concept studies in the catheterization laboratory (13, 14, 111).”
BackgroundSelf-citationNitrite therapy for protection against ischemia-reperfusion injury
Lefer, D. J. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00470.2005 · Cited by 34
“Nitrite has been shown to be a physiological vasodilator substance that regulates regional perfusion in humans (6) and to induce selective pulmonary vasodilation under conditions of hypoxia (8).”
BackgroundProfiling nitric oxide metabolites in patients with idiopathic pulmonary arterial hypertension
Zhang, R., Wang, X., Zhang, H., Sun, X., Zhao, Q., Wang, L., He, J., Jiang, X., Liu, J., & Jing, Z. (2016) · European Respiratory Journal · doi:10.1183/13993003.00245-2016 · Cited by 33
Lteif, C., Ataya, A., & Duarte, J. D. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.020633 · Cited by 33
Sibmooh, N., Piknova, B., Rizzatti, F., & Schechter, A. N. (2008) · Biochemistry · doi:10.1021/bi702158d · Cited by 28
Self-citationEndothelin B receptor stimulation inhibits suicidal erythrocyte death
Föller, M., Mahmud, H., Qadri, S. M., Gu, S., Braun, M., Bobbala, D., Hocher, B., & Lang, F. J. W. (2010) · The FASEB Journal · doi:10.1096/fj.10-159483 · Cited by 28
Ntessalen, M., Procter, N. E. K., Schwarz, K., Loudon, B. L., Minnion, M., Fernandez, B. O., Vassiliou, V. S., Vauzour, D., Madhani, M., Constantin‐Teodosiu, D., et al. (2019) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqz245 · Cited by 29
Hon, Y. Y., Sun, H., Dejam, A., & Gladwin, M. T. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.034355 · Cited by 31
“In addition, the administration of inhaled nebulized nitrite elicited a sustained reduction in hypoxic-induced pulmonary hypertension in newborn lambs (Hunter et al., 2004).”
BackgroundSelf-citationAita, N. A. A., & Mohammed, F. F. (2014) · Global Veterinaria · Cited by 33
Cyclic guanosine monophosphate signalling pathway in pulmonary arterial hypertension
Chen, C.-N., Watson, G., & Zhao, L. (2012) · Vascular Pharmacology · doi:10.1016/j.vph.2012.09.001 · Cited by 29
The role of gasotransmitters in neonatal physiology
Liu, T., Mukosera, G. T., & Blood, A. B. (2019) · Nitric Oxide · doi:10.1016/j.niox.2019.12.002 · Cited by 25
Self-citationDeem, S., Min, J.-H., Moulding, J. D., Eveland, R., & Swenson, E. R. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00812.2006 · Cited by 26
“(22) found that inhaled nebulized nitrite reduced pulmonary artery pressure during hypoxia- and thromboxane-induced pulmonary hypertension in newborn lambs (22).”
BackgroundSchwarz, A., Modun, D., Heusser, K., Tank, J., Gutzki, F., Mitschke, A., Jordan, J., & Tsikas, D. (2010) · Journal of Chromatography B · doi:10.1016/j.jchromb.2010.05.011 · Cited by 26
Discontinued Drugs for the Treatment of Cardiovascular Disease from 2016 to 2018
Li, T., Jiang, S., Ni, B., Cui, Q., Qinan, L., & Zhao, H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184513 · Cited by 27
“Inhaled nitrite of newborn lambs with PH induced by hypoxia elicited a rapid and sustained reduction (approximately 65%) in hypoxia-induced PH, which was deoxyhemoglobin- and pH-dependent, and associated with increased blood levels of iron-nitrosyl-hemoglobin [49].”
BackgroundDias-Junior, C. A., Cáu, S. B. D. A., & Tanus-Santos, J. E. (2008) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37132008000600012 · Cited by 26
Imar, S., Maccato, C., Dickinson, C., Laffir, F. R., Vagin, M. Y., & McCormac∥, T. (2015) · Langmuir · doi:10.1021/la503889j · Cited by 24
Vlasova, E. A., Hessenauer‐Ilicheva, N., Salnikov, D. S., Kudrik, E. V., Makarov, S. V., & van Eldik, R. (2009) · Dalton Transactions · doi:10.1039/b906478h · Cited by 24
Singamsetty, S., Watanabe, Y., Guo, L., Corey, C., Wang, Y., Tejero, J., McVerry, B. J., Gladwin, M. T., Shiva, S., & O'Donnell, C. P. (2015) · The Journal of Physiology · doi:10.1113/jp270386 · Cited by 24
Self-citationKruse, N. T., Ueda, K., Hughes, W. E., & Casey, D. P. (2018) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00015.2018 · Cited by 24
The Nitrate–Nitrite–Nitric Oxide Pathway in Mammals
Lundberg, J. O., Weitzberg, E., Shiva, S., & Gladwin, M. T. (2011) · Humana Press eBooks · doi:10.1007/978-1-60761-616-0_3 · Cited by 27
Self-citationNebulized nitrite protects rat lung grafts from ischemia reperfusion injury
Okamoto, T., Tang, X., Janocha, A., Farver, C. F., Gladwin, M. T., & McCurry, K. R. (2013) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2012.04.006 · Cited by 22
Self-citationTherapeutics Targeting of Dysregulated Redox Equilibrium and Endothelial Dysfunction
Risbano, M. G., & Gladwin, M. T. (2013) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-662-45805-1_13 · Cited by 32
Self-citationGuo, K., & Gao, H. (2021) · Advanced Biology · doi:10.1002/adbi.202100773 · Cited by 26
NO metabolite flux across the human coronary circulation
ROGERS, S., KHALATBARI, A., DATTA, B., ELLERY, S., PAUL, V, FRENNEAUX, M., & JAMES, P. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.04.019 · Cited by 22
Imar, S., Yaqub, M., Maccato, C., Dickinson, C., Laffir, F. R., Vagin, M. Y., & McCormac∥, T. (2015) · Electrochimica Acta · doi:10.1016/j.electacta.2015.10.082 · Cited by 23
“Being extensively used in industrial [7] and biomedical applications [8-10], nitrite is one of the most reactive substances in the nitrogen cycle and has a significant toxicity for humans, being the main cause of blue baby syndrome [11].”
BackgroundNitric oxide and nitrite-based therapeutic opportunities in intimal hyperplasia
Alef, M. J., Tzeng, E., & Zuckerbraun, B. S. (2012) · Nitric Oxide · doi:10.1016/j.niox.2012.03.014 · Cited by 20
Nitrite modulates aminoglycoside tolerance by inhibiting cytochrome heme-copper oxidase in bacteria
Zhang, Y., Guo, K., Meng, Q., & Gao, H. (2020) · Communications Biology · doi:10.1038/s42003-020-0991-4 · Cited by 21
Gritzapis, A. D., Sotiriadou, N. N., Papamichail, M., & Baxevanis, C. N. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-004-0541-9 · Cited by 19
Lukawska, J. J., Livieratos, L., Sawyer, B. M., Lee, T. H., O'Doherty, M. J., Blower, P. J., Kofi, M., Ballinger, J. R., Corrigan, C. J., Gnanasegaran, G., et al. (2014) · EBioMedicine · doi:10.1016/j.ebiom.2014.10.014 · Cited by 19
Nitric Oxide–cGMP Pathway Modulation in an Experimental Model of Hypoxic Pulmonary Hypertension
Reinero, M., Beghetti, M., Tozzi, P., von Segesser, L. K., Samaja, M., & Milano, G. (2021) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/10742484211014162 · Cited by 19
Jankov, R. P., Daniel, K. L., Iny, S., Kantores, C., Ivanovska, J., Fadel, N. B., & Jain, A. (2018) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00184.2018 · Cited by 19
“alternative NO2 -based therapy shown to be strongly protective in adult experimental models of chronic PHT (4, 17, 28, 41, 61).”
BackgroundApplication of nitric oxide in drug discovery and development
Bryan, N. S. (2011) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2011.613933 · Cited by 18
“Moreover, inhalation of nitrite selectively dilates the pulmonary circulation under hypoxic conditions in vivo in sheep [112].”
BackgroundAllylic Nitro Compounds as Nitrite Donors
Chakrapani, H., Gorczynski, M. J., & King, S. B. (2006) · Journal of the American Chemical Society · doi:10.1021/ja066011v · Cited by 19
Parakaw, T., Suknuntha, K., Vivithanaporn, P., Schlagenhauf, A., Topanurak, S., Fucharoen, S., Pattanapanyasat, K., Schechter, A. N., Sibmooh, N., & Srihirun, S. (2017) · Nitric Oxide · doi:10.1016/j.niox.2017.02.008 · Cited by 17
Self-citationYingchoncharoen, T., Rakyhao, T., Chuncharunee, S., Sritara, P., Pienvichit, P., Paiboonsukwong, K., Sathavorasmith, P., Sirirat, K., Sriwantana, T., Srihirun, S., et al. (2017) · Nitric Oxide · doi:10.1016/j.niox.2017.09.010 · Cited by 16
NO‐sensitive guanylyl cyclase in the lung
Friebe, A., & Englert, N. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15345 · Cited by 17
“NO inhalation at ppm to ppb concentrations Nitrovasodilators Main target: native NO-GC Nitrates (e.g., glyceryl trinitrate) — – Biotransformation by mitochondrial aldehyde dehydrogenase – Bronchodilation in COPD patients but not effective in acute asthma patients Nitrites (e.g., inhaled nitrite) — – Biotransformation…”
BackgroundInfluentialEgemnazarov, B., SCHERMULY, R. T., Dahal, B. K., Elliott, G. T., Hoglen, N. C., Surber, M. W., Weißmann, N., Grimminger, F., Seeger, W., & Ghofrani, H. A. (2010) · Respiratory Research · doi:10.1186/1465-9921-11-81 · Cited by 16
“observed increased NOex and reduced HPV after nitrite nebulization in lambs [16].”
BackgroundTherapeutic Implications of Nitrite in Hypertension
Ling, W. C., Mustafa, M. R., & Murugan, D. D. (2019) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000771 · Cited by 15
Fritsch, T., Brouzos, P., Heinrich, K., Kelm, M., Rassaf, T., Hering, P., Kleinbongard, P., & Mürtz, M. (2008) · Nitric Oxide · doi:10.1016/j.niox.2008.03.002 · Cited by 14
“Furthermore its high reliability has been shown in studies toward FIA, HPLC, electron paramagnetic resonance (EPR), Saville assay and CuCl/Cys/CO chemiluminescence [22, 37 ,48,49].”
BackgroundPreserving vessel function during ischemic disease: new possibilities of inorganic nitrite therapy
Kevil, C. G., & Patel, R. P. (2008) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.6.9.1175 · Cited by 14
Wang, K., Wang, R., Fang, Y., Liu, C., Zhu, H., Rong, X., & Zhu, B. (2024) · Talanta · doi:10.1016/j.talanta.2024.126118 · Cited by 13
Reactions of nitrite in erythrocyte suspensions measured by membrane inlet mass spectrometry
Mikulski, R. L., Tu, C., Swenson, E. R., & Silverman, D. N. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.11.003 · Cited by 15
Nitroxyl accelerates the oxidation of oxyhemoglobin by nitrite
Bellavia, L., DuMond, J. F., Perlegas, A. S., King, S. B., & Kim‐Shapiro, D. B. (2013) · Nitric Oxide · doi:10.1016/j.niox.2013.03.006 · Cited by 15
Self-citationValidation of a method to directly and specifically measure nitrite in biological matrices
Almeida, L. E. F., Kamimura, S., Kenyon, N. J., Khaibullina, A., Wang, L., Batista, C. M. D. S., & Quezado, Z. (2014) · Nitric Oxide · doi:10.1016/j.niox.2014.10.008 · Cited by 13
Nitric Oxide Formation From Inorganic Nitrate
Lundberg, J. O., & Weitzberg, E. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804273-1.00012-0 · Cited by 15
Gumanova, N. G., Климушина, М. В., & Metelskaya, V. A. (2018) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-018-4149-z · Cited by 13
Gritzapis, A. D., Perez, S. A., Baxevanis, C. N., & Papamichail, M. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602259 · Cited by 13
Rong, Z., Wilson, M. T., & Cooper, C. E. (2013) · Nitric Oxide · doi:10.1016/j.niox.2013.06.008 · Cited by 12
Nilsson, K. F., Goździk, W., FROSTELL, C. G., Zieliński, S., Zielińska, M., Ratajczak, K., Skrzypczak, P., Rodziewicz, S., Albert, J., & Gustafsson, L. E. (2018) · Drug Design Development and Therapy · doi:10.2147/dddt.s149727 · Cited by 13
Carbonic anhydrase is not a relevant nitrite reductase or nitrous anhydrase in the lung
Pickerodt, P. A., Kronfeldt, S., Russ, M., González-López, A., Lother, P., Steiner, E., Vorbrodt, K., Busch, T., Boemke, W., Francis, R. C. E., et al. (2018) · The Journal of Physiology · doi:10.1113/jp275894 · Cited by 12
Nitrite Prevents Right Ventricular Failure and Remodeling Induced by Pulmonary Artery Banding
HU, J. L., Sharifi‐Sanjani, M., & Tofovic, S. P. (2016) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000446 · Cited by 12
Tuning the Reactivity of Copper(II)–Nitrite Core Towards Nitric Oxide Generation
Kakkarakkal, D. C., Radhamani, R., Bertke, J. A., & Kundu, S. (2024) · Chemistry - A European Journal · doi:10.1002/chem.202403158 · Cited by 10
Nitrate-Reducing Oral Bacteria: Linking Oral and Systemic Health
Bryan, N. S., & Petrosino, J. F. (2017) · Springer eBooks · doi:10.1007/978-3-319-46189-2_3 · Cited by 12
Molecular mechanisms of nitric oxide deposition in erythrocytes
Sybirna, N. O., Lyuta, M. Y., & Klymyshyn, N. I. (2010) · Studia Biologica · doi:10.30970/sbi.0401.080 · Cited by 16
Nilsson, K. F., & Gustafsson, L. E. (2019) · Pharmacology Research & Perspectives · doi:10.1002/prp2.462 · Cited by 10
“3‐43 μmol kg min had pulmonary vasodilatory effects in models of pulmonary hypertension.(36,37) The nebulized inorganic nitrite in these studies also slightly increased FENO,(36,37) which might have arisen from the ventilator circuit and not the animal,(36) whereas intravenous infusions of inorganic nitrite did not af…”
BackgroundIsotope tracing enhancement of chemiluminescence assays for nitric oxide research
Cornelius, J., Tran, T., Turner, N., Piazza, A., Mills, L., Slack, R. L., Hauser, S. J., Alexander, J. S., Grisham, M. B., Feelisch, M., et al. (2008) · Biological Chemistry · doi:10.1515/bc.2009.017 · Cited by 10
“, 2004), deoxyhemoglobin (Cosby et al., 2003; Hunter et al., 2004), myoglobin (Rassaf et al.”
BackgroundCirculating histones as clinical biomarkers in critically ill conditions
García‐Giménez, J. L., Ruiz‐Rodríguez, J. C., Ferrer, R., Durá, R., Artigas, A., Bajaña, I., de Andujar, D. B. L., Cánovas‐Cervera, I., Ceccato, A., Chiscano‐Camón, L., et al. (2025) · FEBS Letters · doi:10.1002/1873-3468.70093 · Cited by 15
Therapeutic Application of Nitric Oxide in Human Diseases
Namkoong, S., & Kim, Y. (2010) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2010.18.4.351 · Cited by 10
“Delivery of sodium nitrite by aerosol in sheep models of PPHN elicited a rapid and sustained reduction (approximately 65%) in hypoxia-induced pulmonary hypertension, with a magnitude approaching that of the effects of 20 ppm NO gas inhalation (Hunter et al., 2004).”
BackgroundS-Nitrosothiols and Nitric Oxide Biology
Patel, R. P., Yuan, S. S., & Kevil, C. G. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804273-1.00004-1 · Cited by 13
Metadata
- Authors
- Hunter, C. J., Dejam, A., Blood, A. B., Shields, H., Kim-Shapiro, D. B., Machado, R. F., Tarekegn, S., Mulla, N., Hopper, A. O., Schechter, A. N., Power, G. G., & Gladwin, M. T.
- Affiliations
- National Institutes of Health (US)
- Loma Linda University Medical Center (US)
- Wake Forest University (US)
- Corresponding author
- Power, Gordon G
- Gladwin, Mark T
- ORCID
- Venue
- Nature Medicine
- Published
- 2004-09-12
- Volume
- 10
- Issue
- 10
- Pages
- 1122-1127
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2116376555
- Cited by
- 281
- References
- 32
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 4 · 2023: 1 · 2022: 4 · 2021: 8 · 2020: 5 · 2019: 10 · 2018: 15 · 2017: 17 · 2016: 14 · 2015: 12 · 2014: 15 · 2013: 12 · 2012: 23
- FWCI
- 16.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HL58091, R01HL058091, HL654941)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Neonatal Respiratory Health Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
- Keywords
- sodium nitrite, nitric oxide, neonatal pulmonary hypertension, deoxyhemoglobin, methemoglobin, right-to-left shunt, hypoxemia, newborn lambs
- MeSH terms
- Administration, Inhalation, Aerosols, Animals, Animals, Newborn, Hypoxia, Blood Pressure, Cardiac Output, Disease Models, Animal, Hemoglobins, Humans, Hydrogen-Ion Concentration, Infant, Newborn, Methemoglobin, Nitric Oxide, Oxygen, Persistent Fetal Circulation Syndrome, Sheep, Sodium Nitrite, Vasodilator Agents, 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.